Skip to main content
Immunology logoLink to Immunology
. 1984 Jul;52(3):555–562.

Natural killing and growth inhibition of K562 cells by subpopulations of mononuclear cells as a function of target cell proliferation.

G Hagner
PMCID: PMC1454504  PMID: 6611299

Abstract

K562 cells of different proliferative activity were tested for their capability to form lytic and non-lytic conjugates in agarose with peripheral blood mononuclear cells (MNC). Simultaneously, the conjugating MNC were analysed in suspension by monoclonal antibodies (mAb) defining subsets of T cells, natural killer (NK) cells, and monocytes (OKT 8, OKT 4, Leu 7, OKM 1, Mo 2). It is demonstrated that the pattern of conjugating (binding, lysis) is dependent upon the proliferative status of the target cell population. Target cells of intermediate division rate are optimally lysed by MNC of NK phenotype, whereas targets of high and low division rate bind cells predominantly of T cell phenotype, but are not killed. Non-cytolytic conjugating MNC are shown to inhibit significantly the cell cycle progression of their bound tumour target cells. There is evidence of an additional cytostatic effect on non-bound K562 cells in agarose dishes containing effector MNC, possibly mediated by soluble factors released from NK cells. Adherent monocytes contribute only little to cytolysis and cytostasis in our testing system. There is no correlation between the expression of transferrin receptors on target cells as determined by the OKT9 mAb and the extent of killing. Transferrin receptors may, however, be involved in the step of target cell recognition by MNC exhibiting the OKT 8+ phenotype.

Full text

PDF
555

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abo T., Balch C. M. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol. 1981 Sep;127(3):1024–1029. [PubMed] [Google Scholar]
  2. Abo T., Cooper M. D., Balch C. M. Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability. J Immunol. 1982 Oct;129(4):1752–1757. [PubMed] [Google Scholar]
  3. Breard J., Reinherz E. L., Kung P. C., Goldstein G., Schlossman S. F. A monoclonal antibody reactive with human peripheral blood monocytes. J Immunol. 1980 Apr;124(4):1943–1948. [PubMed] [Google Scholar]
  4. Gidlund M., Orn A., Pattengale P. K., Jansson M., Wigzell H., Nilsson K. Natural killer cells kill tumour cells at a given stage of differentiation. Nature. 1981 Aug 27;292(5826):848–850. doi: 10.1038/292848a0. [DOI] [PubMed] [Google Scholar]
  5. Grimm E., Bonavida B. Mechanism of cell-mediated cytotoxicity at the single cell level. I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency. J Immunol. 1979 Dec;123(6):2861–2869. [PubMed] [Google Scholar]
  6. Hansson M., Kärre K., Kiessling R., Roder J., Andersson B., Häyry P. Natural NK-cell targets in the mouse thymus: characteristics of the sensitive cell population. J Immunol. 1979 Aug;123(2):765–771. [PubMed] [Google Scholar]
  7. Jondal M., Pross H. Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int J Cancer. 1975 Apr 15;15(4):596–605. doi: 10.1002/ijc.2910150409. [DOI] [PubMed] [Google Scholar]
  8. Kaplan J., Callewaert D. M. Expression of human T-lymphocyte antigens by natural killer cells. J Natl Cancer Inst. 1978 May;60(5):961–964. doi: 10.1093/jnci/60.5.961. [DOI] [PubMed] [Google Scholar]
  9. Kay H. D., Horwitz D. A. Evidence by reactivity with hybridoma antibodies for a probable myeloid origin of peripheral blood cells active in natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Clin Invest. 1980 Oct;66(4):847–851. doi: 10.1172/JCI109923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lozzio C. B., Lozzio B. B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975 Mar;45(3):321–334. [PubMed] [Google Scholar]
  11. Perussia B., Fanning V., Trinchieri G. A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8. J Immunol. 1983 Jul;131(1):223–231. [PubMed] [Google Scholar]
  12. Reinherz E. L., Kung P. C., Goldstein G., Schlossman S. F. A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2. J Immunol. 1980 Mar;124(3):1301–1307. [PubMed] [Google Scholar]
  13. Reinherz E. L., Kung P. C., Goldstein G., Schlossman S. F. Further characterization of the human inducer T cell subset defined by monoclonal antibody. J Immunol. 1979 Dec;123(6):2894–2896. [PubMed] [Google Scholar]
  14. Roder J. C., Rosén A., Fenyö E. M., Troy F. A. Target-effector interaction in the natural killer cell system: isolation of target structures. Proc Natl Acad Sci U S A. 1979 Mar;76(3):1405–1409. doi: 10.1073/pnas.76.3.1405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rubin P., Pross H. F., Roder J. C. Studies of human natural killer cells. II. Analysis at the single cell level. J Immunol. 1982 Jun;128(6):2553–2558. [PubMed] [Google Scholar]
  16. Sutherland R., Delia D., Schneider C., Newman R., Kemshead J., Greaves M. Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4515–4519. doi: 10.1073/pnas.78.7.4515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Targan S., Dorey F. Interferon activation of "pre-spontaneous killer" (pre-SK) cells and alteration in kinetics of lysis of both "pre-SK" and active SK cells. J Immunol. 1980 May;124(5):2157–2161. [PubMed] [Google Scholar]
  18. Todd R. F., 3rd, Nadler L. M., Schlossman S. F. Antigens on human monocytes identified by monoclonal antibodies. J Immunol. 1981 Apr;126(4):1435–1442. [PubMed] [Google Scholar]
  19. Vodinelich L., Sutherland R., Schneider C., Newman R., Greaves M. Receptor for transferrin may be a "target" structure for natural killer cells. Proc Natl Acad Sci U S A. 1983 Feb;80(3):835–839. doi: 10.1073/pnas.80.3.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wright S. C., Bonavida B. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells. J Immunol. 1982 Jul;129(1):433–439. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES